Eureka Therapeutics
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. They have developed E-ALPHA into one of the world’s largest human-derived antibody phage libraries to generate target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets.
Domain
eurekatherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$10.6M
Founded
2005
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Eureka Therapeutics use?+
Eureka Therapeutics uses 22 technologies including Chart.js, Contact Form 7, Elementor.
What industry is Eureka Therapeutics in?+
Eureka Therapeutics operates in the Biotechnology industry.
Where is Eureka Therapeutics based?+
Eureka Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026